TKTakeharu Koga

Takeharu Koga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Takeharu Koga has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Nasal Condition on Self-assessed Disease Control and Treatment Satisfaction in Patients with Asthma Complicated by Allergic Rhinitis

    by Takeharu Koga, Hiroto Matsuse, Hirotsugu Kohrogi, Shigeru Kohno, Hisamichi Aizawa

    BackgroundBodies of evidences have suggested that upper and lower airways are intricately interconnected with each other in patients with allergic airways diseases, however, few data are available concerning the impact of allergic rhinitis on self-assessed asthma condition and treatment satisfaction. The present study was conducted to clarify the association between nasal condition and self-assessment of asthma control and treatment satisfaction.MethodsAdult patients with asthma were consecutively recruited for a systematic self-administered questionnaire to obtain information on nasal condition, self-perceived condition of asthma, and asthma treatment satisfaction.Results3,140 adult patients with asthma completed the questionnaire, and of these 634 patients (mean age: 53.1, 389 female) had physician-diagnosed allergic rhinitis. There were significant correlations between nasal symptoms (sneeze, rhinorrhea, nasal obstruction) and self-perceived asthma condition (limited daily activity, wheeze, dyspnea/chest tightness, cough, sputum, sleep disturbance, overall asthma condition). Patients who considered their overall nasal condition as unfavorable or bad were more likely than those who considered their condition as good or favorable to be dissatisfied with asthma treatment (p<0.01).Conclusions: Nasal condition is closely associated with self-assessed asthma condition and asthma treatment satisfaction. Controlling allergic rhinitis is critical to attain optimal management of asthma in patients complicated by allergic rhinitis


  • Obesity and Public Health Law

    by Takeharu Koga, Atsushi Kawaguchi, Hisamichi Aizawa

    Mello et al. (June 15 issue)1 discuss obesity as the new frontier of public health law. Public strategies including legislative regulation against obesity must take into account the fact that obesity is closely associated with low income.2 Obesity in low-income families originates at an early stage of life, possibly through unhealthy food selection3 and eating patterns and a sedentary lifestyle.4 Aside from economic considerations, a lack of knowledge about5 and a limited access to6 healthy food choices seem to be crucial aspects of the problem. Therefore, strategies against obesity need to encompass educational efforts to promote a healthy lifestyle and remove obstacles to the achievement of that goal for persons at high risk for obesity.


  • Pneumonia: … and to tuberculosis as differential diagnosis in community acquired pneumonia

    by Takeharu Koga, Hisamichi Aizawa

    Footnotes Competing interests None declared.

  • Characterisation of patients with frequent exacerbation of asthma

    by Takeharu Koga, Yuichi Oshita, Tomoko Kamimura, Hideyuki Koga, Hisamichi Aizawa


  • Determinants of Bronchodilator Responsiveness in Patients with Controlled Asthma

    by Takeharu Koga, Tomoko Kamimura, Yuichi Oshita, Yuko Narita, Tatsuya Mukaino, Munetsugu Nishimura, Yusuke Mizoguchi, Hisamichi Aizawa

    Short-term bronchodilator responsiveness to an inhaled β 2 adrenergic agonist was assessed by changes in forced expiratory volume in 1 second (FEV1) in nonsmoking adults with controlled asthma (mild disease, 20 patients; moderate disease, 20 patients; severe disease, 18 patients). Responsiveness correlated significantly with age and with percent of predicted FEV1 (%FEV1) except in patients with severe asthma, who showed significantly less responsiveness than others. Thus, responsiveness is closely associated with degree of airflow limitation in patients with controlled asthma and is significantly influenced by severity of disease and by aging.


  • Open Access

    Pulmonary Metastasis of Endometrial Stromal Sarcoma

    by Takeharu Koga, Kimio Ushijima, Masayoshi Kage, Masao Ichiki, Takao Kitajima, Yuko Narita, Yusuke Mizoguchi, Mikiko Hanada, Ryu Ehara, Munetsugu Nishimura, et al.

    Multiple round opacities suggestive of metastatic lung tumors were incidentally found on a chest x-ray film in a 43-year-old woman. The patient underwent hysterectomy for “myoma uteri” three years previously. Extensive examinations could not specify the primary neoplastic lesions. Morphological characteristics of the thracoscopically resected lung tumors suggested low-grade endometrial stromal sarcoma (ESS), and immunostaining revealed that the tumor cells were positive for progesterone and estrogen receptors, CD10 and vimentin, confirming a diagnosis of ESS. ESS is an uncommon uterine neoplasm, however, may be mistaken as benign tumors such as epithelioid leiomyoma, and occasionally metastasizes to remote organs such as lungs even after long disease-free period, posing diagnostic challenge.


  • Chronic pulmonary scedosporiosis simulating aspergillosis

    by Takeharu Koga, Takao Kitajima, Reiko Tanaka, Masashi Hirokawa, Masao Ichiki, Toru Rikimaru, Hisamichi Aizawa

    Scedosporium apiospermum, a ubiquitously distributed saprophyte, is emerging as an important pathogen in immunocompromised patients. We describe a 72‐year‐old patient with chronic S. apiospermum infection of the lung simulating aspergilloma. His medical history was unremarkable except that he had undergone partial lung resection as a treatment for pulmonary tuberculosis several decades previously. He had no underlying immunosuppressive conditions. This patient illustrates that pulmonary scedosporiosis is not confined to immunocompromised patients and that the clinical presentation may be indistinguishable from that of aspergilloma.


  • Open Access

    Recurrent pneumonia in a 38-year-old female

    by T. Koga, J. Ikeda, K. Fujimoto, S. Takamori, M. Kinoshita, H. Aizawa

    ExtractA 38-year-old Japanese female was referred to Kurume University Hospital (Kurume, Japan) because of recurrent pneumonia. She had no particular medical history, had never undergone a blood transfusion and was taking no regular medication or treatment. She had a negative smoking history, did not own any pets and denied a history of dust exposure. Her family history was unremarkable. She had successfully completed three vaginal deliveries and had been well until the age of 35 years, which is when she experienced her first episode of pneumonia. The pneumonia was cured by the administration of β-lactam antibiotics. She then suffered three more episodes of pneumonia within 3 years. She denied any history of accidental aspiration, weight loss or haemoptysis, and did not have pyrexia, night sweats or sputum production between the episodes of pneumonia.

  • Bronchial Manifestation of Adverse Drug Reaction

    by Yuichi Oshita, Takeharu Koga, Tomoko Kamimura, Hisamichi Aizawa

    Adverse drug reactions can affect many organs and produce diverse clinical manifestations. Lungs are frequently affected, being commonly recognized as parenchymal diseases. We describe a patient whose central airways are primarily affected in an adverse drug reaction. The present case illustrates that not only lung parenchyma, but also bronchus, can be targeted in drug-induced lung diseases.

  • Open Access

    Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma

    by Y Oshita, T Koga, T Kamimura, K Matsuo, T Rikimaru, H Aizawa

    Background: The 72 kDa matrix metalloproteinase 2 (MMP-2) and the 92 kDa matrix metalloproteinase 9 (MMP-9) are type IV collagenases implicated in various aspects of inflammation including accumulation of inflammatory cells, tissue injury, and development of remodelling. The role of these enzymes in the pathogenesis of asthma exacerbations is unknown. Methods: Circulating levels of MMP-2 and MMP-9 proteins and the expression of their inhibitor, tissue inhibitor of metalloproteinase 1 (TIMP-1), were measured in 21 patients experiencing an asthma exacerbation and 21 age matched patients with stable asthma. Circulating gelatinolytic activity was compared during the asthma exacerbation and during subsequent convalescence by gelatin zymography in the same individuals. In addition, MMP-9 specific activity was quantified with a colorimetric assay which uses an artificial proenzyme containing a specific domain recognised by MMP-9 in the same paired samples. Results: A significant increase in the circulating level of MMP-9 was seen in patients with an asthma exacerbation compared with patients with stable asthma (202.9 (22.0) v 107.7 (9.9) ng/ml, p=0.0003). There were no significant differences in the circulating levels of MMP-2 or TIMP-1. Gelatin zymography identified two major circulating gelatinolytic activities corresponding to MMP-2 and MMP-9, and showed that asthma exacerbations are characterised by markedly increased MMP-9 activity with no significant change in MMP-2 activity compared with the activities during convalescence in the same individuals. Direct measurement showed that MMP-9 specific activity is significantly increased during asthma exacerbations compared with subsequent convalescence (269.6 (31.7) v 170.4 (12.6) ng/ml, p=0.0099). Conclusions: Asthma exacerbations are characterised by increased circulating MMP-9 activity. This increased activity may be related to exaggerated airway inflammation and airway remodelling.